Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer

Prof Benjamin Besse and Dr Alex Spira

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer ( Prof Benjamin Besse and Dr Alex Spira )

Ensuring quality care for breast cancer patients globally

Dr Didier Verhoeven - University of Antwerp, Antwerp, Belgium

Ensuring quality care for breast cancer patients globally ( Dr Didier Verhoeven - University of Antwerp, Antwerp, Belgium )

Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple...

Dr Shaji Kumar - Mayo Clinic, Rochester, USA

$Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )$

KRd vs VRd for initial therapy of newly diagnosed multiple myeloma

Dr Shaji Kumar - Mayo Clinic, Rochester, USA

KRd vs VRd for initial therapy of newly diagnosed multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )

Teclistamab for patients with heavily pretreated relapsed or refractory...

Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA

$Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma ( Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA )$

E2108: Systemic therapy plus early local therapy versus systemic therapy alone...

Dr Seema Ahsan Khan - Northwestern Memorial Hospital, Chicago, USA

E2108: Systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer ( Dr Seema Ahsan Khan - Northwestern Memorial Hospital, Chicago, USA )

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy...

Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-stage small-cell lung cancer ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA )

EAU guidelines for treating patients with advanced prostate cancer

Dr Eleni Efstathiou, Prof Álvaro Pinto, Prof Nicolas Mottet and Prof Heather...

EAU guidelines for treating patients with advanced prostate cancer ( Dr Eleni Efstathiou, Prof Álvaro Pinto, Prof Nicolas Mottet and Prof Heather Payne )

Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and...

Dr Dimpy Shah - Mays Cancer Center at UT Health San Antonio MD Anderson, San...

Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19) ( Dr Dimpy Shah - Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA )

Cumulative incidence of financial hardship in metastatic colorectal cancer...

Dr Veena Shankaran - Fred Hutchinson Cancer Research Center, Seattle, USA

Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD ( Dr Veena Shankaran - Fred Hutchinson Cancer Research Center, Seattle, USA )

Denosumab in multiple myeloma patients with renal insufficiency

Dr Elizabeth O'Donnell - Massachusetts General Hospital, Boston, USA

Denosumab in multiple myeloma patients with renal insufficiency ( Dr Elizabeth O'Donnell - Massachusetts General Hospital, Boston, USA )

Association of BRCA alterations with response to PARP inhibitors in metastatic...

Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer...

Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer ( Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )

More from ecancer